Similar articles

• Monitoring of blood coagulation in open heart surgery. II. Use of individualized dosages of heparin and protamine controlled by activated coagulation times.

  Dercksen SJ, Linssen GH. Dercksen SJ, et al. Acta Anaesthesiol Belg. 1980;31(2):121-8. Acta Anaesthesiol Belg. 1980. PMID: 7468138
• [Activated coagulation time and the concentration of heparin in assessing the level of blood heparinization during operations using artificial blood circulation].

  Khodas MIa, Piatnitskaia GKh, Savina ME, Smirnova LA. Khodas MIa, et al. Anesteziol Reanimatol. 1989 Mar-Apr;(2):11-5. Anesteziol Reanimatol. 1989. PMID: 2742179 Russian.
• [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].

  Daudt CA, Pereira SN, Moraes LB, Costa PS, Deboni LM, Figueiredo MS. Daudt CA, et al. Arq Bras Cardiol. 1989 Mar;52(3):137-9. Arq Bras Cardiol. 1989. PMID: 2597000 Portuguese.
• Safety issues in heparin and protamine administration for extracorporeal circulation.

  Jobes DR. Jobes DR. J Cardiothorac Vasc Anesth. 1998 Apr;12(2 Suppl 1):17-20. J Cardiothorac Vasc Anesth. 1998. PMID: 9583571 Review.
• [Cardiac surgery as a significant interference with a patient coagulation status].

  Brát R. Brát R. Vnitr Lek. 2009 Mar;55(3):233-5. Vnitr Lek. 2009. PMID: 19378853 Review. Czech.